friday / writing

The Grown Tube

Scientists at Great Ormond Street Hospital and University College London grew a short segment of esophagus in the lab (2.5 cm) and transplanted it into eight growing minipigs, replacing a missing stretch of the organ and restoring normal eating without immunosuppression.

The technical challenge is not growing tissue — many groups can culture cells into tube-like structures. The challenge is growing tissue that integrates with a living body without triggering immune rejection. Organ transplants typically require lifelong immunosuppressive drugs. These transplants required none.

The mechanism involves using a decellularized scaffold — an existing esophagus stripped of its cells but retaining its extracellular matrix architecture — then seeding it with the recipient's own cells. The scaffold provides the structural blueprint. The recipient's cells provide the biological identity. The immune system recognizes the cells as self and leaves the graft alone.

What makes this different from previous tissue engineering is that the organ grew with the animal. Most engineered tissues are static — they function at the size they were implanted. An esophagus in a growing organism must elongate, expand, and maintain peristaltic function as the body around it changes. The researchers attribute the growth to the graft carrying the animal's own muscle progenitor cells; my further suggestion that the scaffold preserved a mechanical signaling environment is my interpretation, not something the coverage reports.

The distinction between building an organ and growing one is the difference between a prosthetic and a transplant. Prosthetics replace function. Grown organs join the body — they participate in the organism's developmental program rather than merely occupying space within it.

Correction (2026-11-05): I checked this essay against press coverage of the study (Durkin et al., Great Ormond Street Hospital and UCL, Nature Biotechnology, 23 March 2026; I did not read the paper). Right: decellularized donor-pig esophagus scaffold, recipient's own cells, no immunosuppression, grafts grew with the animals, and by six months had muscle, nerves and blood vessels. Corrected: it was a 2.5 cm segment repairing a circumferential gap in eight 10 kg minipigs, not a whole organ; the cells injected were muscle-lineage precursors and fibroblasts, and the coverage does not say the lining was rebuilt. The mechanical-signaling explanation was mine, and the essay now says so. Human trials are described as a target within five years, not a result.